Intec Pharma Ltd (NTEC)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

12 HARTOM STREET JERUSALEM, ISRAEL 777512

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

Data as of 2021-08-02 08:46:06 -0400
Market Cap83.217 Million Shares Outstanding7.371 Million Avg 30-day Volume2.239 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.20372 52-week High/Low36.88 / 8.8 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -2.945
Data provided by IEX Cloud

Are you looking for these stocks instead?

View SEC Filings from NTEC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 19 -94.74% (0.0%) 7 (0.41%)
13F shares: 890 615.217 Thousand -99.86% 0 183.653 Thousand -100.0%
% Ownership 0.0198 15.5821 -99.87% 0.0 4.6515 -100.0%
New Positions: 1 5 -80.0% 2
Increased Positions 8 5
Closed Positions 18 11 63.64% 7 2 250.0%
Reduced Positions 3
Total Calls 0 1.3 Thousand -100.0% 0
Total Puts 0 6 -100.0%
PUT/CALL Ratio 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NTEC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NTEC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SASSI NIR CHIEF FINANCIAL OFFICER

  • Officer
0 2020-09-16 1

LINSCOTT WALT ADDISON CHIEF BUSINESS OFFICER

  • Officer
0 2020-09-16 1

NAVON NADAV CHIEF OPERATING OFFICER

  • Officer
0 2020-09-16 1

MADDALUNA ANTHONY J

  • Director
0 2020-07-15 0

KARAH HILA

  • Director
0 2020-07-15 0

HAYES WILLIAM B

  • Director
0 2020-07-15 0

POMERANTZ ROGER

  • Director
0 2020-07-15 0

KOZARICH JOHN W

  • Director
0 2020-07-15 0

MECKLER JEFFREY A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-07-15 0

GENDREAU R MICHAEL CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-17 0

DEXCEL PHARMA TECHNOLOGIES LTD.

OREN DAN

  • 10% Owner
No longer subject to file 2020-01-31 0

SILBERMAN ISSAC

  • Director
4,000 2019-11-19 0

BIANCO GIL

  • Director
0 2019-06-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INTEC PHARMA LTD NTEC 2021-08-02 22:15:03 UTC -96.418 96.478 500
INTEC PHARMA LTD NTEC 2021-08-02 21:45:03 UTC -96.418 96.478 500
INTEC PHARMA LTD NTEC 2021-08-02 21:15:03 UTC -96.418 96.478 500
INTEC PHARMA LTD NTEC 2021-07-27 22:15:03 UTC -42.9179 42.9979 100000
INTEC PHARMA LTD NTEC 2021-07-27 21:45:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 21:15:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 20:45:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 20:15:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 19:45:02 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 19:15:02 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 18:45:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 18:15:02 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 17:45:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 17:15:03 UTC -0.17 0.25 100000
INTEC PHARMA LTD NTEC 2021-07-27 16:45:02 UTC -0.17 0.25 40000
INTEC PHARMA LTD NTEC 2021-07-27 16:15:03 UTC -0.17 0.25 40000
INTEC PHARMA LTD NTEC 2021-07-27 15:45:03 UTC -0.17 0.25 40000
INTEC PHARMA LTD NTEC 2021-07-26 22:15:03 UTC -92.5904 92.6704 15000
INTEC PHARMA LTD NTEC 2021-07-26 21:45:04 UTC -92.6026 92.6826 15000
INTEC PHARMA LTD NTEC 2021-07-26 21:15:03 UTC -92.6026 92.6826 15000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments